v3.25.2
IPO and Restructuring (Details) - USD ($)
6 Months Ended
Mar. 10, 2025
Mar. 07, 2025
Feb. 14, 2025
Jun. 30, 2025
Dec. 31, 2024
IPO and Restructuring [Line Items]          
Amount paid (in Dollars) $ 200,000        
Percentage of shares outstanding       96.00%  
Issuance shares       3,782,641  
Restructuring amount       77.30%  
Aggregate principal amount (in Dollars)       $ 1,006,377  
Common stock authorized       50,000,000 200,000
Warrants [Member]          
IPO and Restructuring [Line Items]          
Outstanding warrants       1,125  
Brookstone Partners IAC [Member]          
IPO and Restructuring [Line Items]          
Amount paid (in Dollars) $ 200,000,000        
BPA XIV, LLC [Member]          
IPO and Restructuring [Line Items]          
Restructuring amount       64.00%  
Common Stock [Member]          
IPO and Restructuring [Line Items]          
Interests exchanged amount       3,782,641  
Common stock authorized       50,000,000  
Preferred Stock [Member]          
IPO and Restructuring [Line Items]          
Peferred stock       25,000,000  
BP Peptides, LLC [Member]          
IPO and Restructuring [Line Items]          
Restructuring amount       3.00%  
Public Offering Shares [Member]          
IPO and Restructuring [Line Items]          
Public offering price (in Dollars per share)     $ 4    
Public Offering Shares [Member] | Common Stock [Member]          
IPO and Restructuring [Line Items]          
Shares of common stock   1,250,000      
Underwriting discounts [Member]          
IPO and Restructuring [Line Items]          
Net proceeds (in Dollars)     $ 3,252,000